Recommendations from Industry-Led Reagan-Udall Roundtable on Controlling C. botulinum in Infant Formula

Following two unprecedented infant botulism outbreaks linked to ByHeart- and Nara Organics-brand powdered infant formula in 2025–2026, a new report from the Reagan-Udall Foundation has outlined recommendations intended to advance scientific understanding of Clostridium botulinum risks and strengthen controls throughout the infant formula supply chain.

Read more.